{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:39:29Z","timestamp":1768009169142,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Department of Science","award":["SAF2012-39578"],"award-info":[{"award-number":["SAF2012-39578"]}]},{"name":"Spanish Department of Science","award":["SAF2015-65157-R"],"award-info":[{"award-number":["SAF2015-65157-R"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jconrel.2017.10.032","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T02:31:36Z","timestamp":1508812296000},"page":"247-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-6371","authenticated-orcid":false,"given":"Joanna","family":"Poutou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bunuales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Gonzalez-Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-5765","authenticated-orcid":false,"given":"Beatriz","family":"German","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zugasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2598","authenticated-orcid":false,"given":"Ruben","family":"Hernandez-Alcoceba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.10.032_bb0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/13543784.2013.793307","article-title":"Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives","volume":"22","author":"Hernandez-Alcoceba","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"164","key":"10.1016\/j.jconrel.2017.10.032_bb0010","first-page":"3112","article-title":"Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy","volume":"1950","author":"Narvaiza","year":"2000","journal-title":"J. Immunol. (Baltimore, MD)"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cbpa.2017.03.010","article-title":"Targeting ligand\u2013receptor interactions for development of cancer therapeutics","volume":"38","author":"Kim","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymeth.2013.06.036","article-title":"Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions","volume":"65","author":"Kellner","year":"2014","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc3973","article-title":"Evolving synergistic combinations of targeted immunotherapies to combat cancer","volume":"15","author":"Melero","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-017-1678-1","article-title":"New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management","volume":"21","author":"Kroschinsky","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0040","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0045","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2004.04.059","article-title":"Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors","volume":"22","author":"Sangro","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/cgt.2010.40","article-title":"A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma","volume":"17","author":"Sangro","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1053\/j.gastro.2005.03.024","article-title":"Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients","volume":"128","author":"Penuelas","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(03)01139-2","article-title":"Why did p53 gene therapy fail in ovarian cancer?","volume":"4","author":"Zeimet","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0075","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/hum.2013.071","article-title":"Transgene expression up to 7years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors","volume":"24","author":"Brunetti-Pierri","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"Suppl. 5","key":"10.1016\/j.jconrel.2017.10.032_bb0080","first-page":"1","article-title":"Helper-Dependent Adenoviral Vectors","author":"Rosewell","year":"2011","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/hum.2009.096","article-title":"Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories","volume":"21","author":"Suzuki","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0090","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-insependent gene transfer","volume":"58","author":"Miller","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0095","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0100","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/humrep\/deq137","article-title":"A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect","volume":"25","author":"Paupoo","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0105","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/nbt1196-1570","article-title":"Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types","volume":"14","author":"Wickham","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0110","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a Coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1743-6109.2006.00168.x","article-title":"Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds","volume":"14","author":"Stoff","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctrv.2013.04.004","article-title":"Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies","volume":"40","author":"Heinemann","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2012.03.001","article-title":"Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issues","volume":"48","author":"Manfredsson","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/srep27697","article-title":"Improvement of the reverse tetracycline transactivator by single amino acid substitutions that reduce leaky target gene expression to undetectable levels","volume":"6","author":"Roney","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1089\/10430340260201707","article-title":"Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression","volume":"13","author":"Latta-Mahieu","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0140","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.76.22.11605-11611.2002","article-title":"Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus","volume":"76","author":"Favre","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.96.2.355","article-title":"Adenovirus-mediated regulable target gene expression in vivo","volume":"96","author":"Burcin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2003.10.075","article-title":"Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer","volume":"126","author":"Wang","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gut.2010.211722","article-title":"Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice","volume":"60","author":"Gonzalez-Aparicio","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0160","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gt.2015.45","article-title":"Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model","volume":"22","author":"Poutou","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.35","article-title":"Adeno-associated virus-mediated, mifepristone-regulated transgene expression in the brain","volume":"2","author":"Maddalena","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0170","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.4158\/EP11391.CR","article-title":"Successful long-term treatment of cushing disease with mifepristone (RU486)","volume":"18","author":"Basina","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/07357900601062339","article-title":"Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of me","volume":"24","author":"Grunberg","year":"2006","journal-title":"Cancer Investig."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-1119(03)00506-7","article-title":"Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems","volume":"309","author":"Xu","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0190","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ymthe.2006.05.021","article-title":"Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery","volume":"14","author":"Koh","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.7809612","article-title":"Structure-based design of transcription factors","volume":"267","author":"Pomerantz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0200","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/mt.2011.37","article-title":"Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer","volume":"19","author":"Vanrell","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0205","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.mt.6300305","article-title":"One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications","volume":"15","author":"Barcia","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transformants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2005.02.017","article-title":"IFN-\u03b1 gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes","volume":"12","author":"Berraondo","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/mthe.2002.0532","article-title":"Generation of helper-dependent adenoviral vectors by homologous recombination","volume":"5","author":"Toietta","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0225","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/gt.2011.58","article-title":"Self-inactivating helper virus for the production of high-capacity adenoviral vectors","volume":"18","author":"Gonzalez-Aparicio","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1038689","article-title":"New role of Interleukin-10 in enhancing the antitumor efficacy of oncolytic vaccinia virus for treatment of pancreatic cancer","volume":"4","author":"Chard","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/hum.2009.020","article-title":"Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver","volume":"20","author":"Jager","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/mthe.2000.0115","article-title":"Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system","volume":"2","author":"Abruzzese","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0245","article-title":"Target-mediated disposition model describing the dynamics of IL12 and IFNgamma after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice","author":"Parra-Guillen","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0250","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/104303401300042500","article-title":"CMV-b-actin promoter directs higher expression from an adeno-associated viral vector in the liveer than the cytomegalovirus or elongation factor 1a promoter and results in therapeutic levels of human factor X in mice","volume":"12","author":"Xu","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/scd.2006.0057","article-title":"Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner","volume":"16","author":"Xia","year":"2007","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0260","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jgm.2675","article-title":"Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors","volume":"14","author":"Robert","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2016.07.004","article-title":"Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery","volume":"237","author":"Rojas","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mt.2010.229","article-title":"Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells","volume":"19","author":"Prill","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.10.032_bb0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-8-2","article-title":"Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy","volume":"8","author":"Zabala","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2017.10.032_bb0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.gt.3303073","article-title":"Interleukin-12 inhibits liver-specific drug-inducible systems in vivo","volume":"15","author":"Reboredo","year":"2008","journal-title":"Gene Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917309318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917309318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:02:26Z","timestamp":1603188146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917309318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":56,"alternative-id":["S0168365917309318"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.10.032","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}